This federal Project Grant award of $619,969 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop and validate an advanced AI-powered mobile diagnostic tool called "DEEPSTROKE+" for rapid and precise detection of acute strokes. The research, conducted by The Methodist Hospital Research Institute (HMRI) in Houston, Texas, will focus on...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund the development and testing of a Fused Imaging and Large Language Foundational Model (FILLM) to predict 90-day outcomes for acute ischemic stroke patients eligible for endovascular therapy. The $124,485 award to The Leland Stanford Junior University (Stanford University)...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the use of elovanoids (EVLs), a class of lipid mediators, to protect the penumbra (ischemic tissue surrounding the core infarct) in experimental ischemic stroke. The $481,617 award to Louisiana State University Health Sciences Center New Orleans...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $221,120.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on improving neural progenitor cell survival and migration in the context of neurodegenerative diseases and brain injuries, such as stroke. The research investigates...
This $1,149,995.00 Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Program (CFDA 47.070) supports research at New York University (NYU) School of Medicine to develop innovative methods in artificial intelligence (AI) and motion capture technology to analyze patient movement and improve stroke rehabilitation. The key objectives of the project are to: 1) develop a method to integrate multimodal data into a shared representation...
The University of Texas Health Science Center at Houston (UTHealth) received a federal Project Grant award of $617,687 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program. The goal of this 5-year project is to build infrastructure for community-engaged research interventions focused on addressing racial and ethnic disparities in three key neurological...
The National Institute on Aging (NIA) awarded a $2,340,263 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Emory University. The grant, titled "Using AI on Routine Clinical and Imaging Data from Acute Stroke Encounter to Predict Post-Stroke Vascular Contributions to Cognitive Impairment (AI - RESPECT)," aims to develop machine learning models to predict post-stroke cognitive impairment (PSCI) using electronic health record data and neuroimaging. The...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $423,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Augusta University Research Institute, Inc. The objective is to develop and evaluate engineered exosomes carrying neuron-targeting peptides and a therapeutic protein (neuroglobin) for treating ischemic stroke. The research will: 1) characterize the engineered exosomes and assess their...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,223,140 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Chicago. The goal of this 5-year research project is to test a novel biopharmaceutical agent called Sanguinate that is designed to boost arterial collateralization and deliver oxygen to ischemic tissue in acute ischemic stroke patients. The research aims to determine if this...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports the development of a novel aspiration pump for neurointerventional procedures. The $1,386,770 award to VON Vascular, Inc. will fund the refinement and validation of this innovative aspiration technology using physiologically relevant soft and hard clots. The...